SCM

Superstring Capital Management Portfolio holdings

AUM $102M
1-Year Est. Return 67.26%
This Quarter Est. Return
1 Year Est. Return
+67.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$102M
AUM Growth
+$21.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
51
New
Increased
Reduced
Closed

Top Buys

1
+$6.56M
2
+$5.5M
3
+$4.08M
4
IQV icon
IQVIA
IQV
+$3.63M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.6M

Top Sells

1
+$8.64M
2
+$6.52M
3
+$5.33M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$5.1M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$4.74M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRRK icon
26
Scholar Rock
SRRK
$4.28B
$1.47M 1.45%
+39,521
PTGX icon
27
Protagonist Therapeutics
PTGX
$5.35B
$1.35M 1.33%
+20,358
TVTX icon
28
Travere Therapeutics
TVTX
$3.15B
$1.28M 1.26%
53,627
-222,847
ORIC icon
29
Oric Pharmaceuticals
ORIC
$1.09B
$1.07M 1.06%
89,346
-255,576
RAPT icon
30
RAPT Therapeutics
RAPT
$873M
$888K 0.88%
34,449
+8,415
VIR icon
31
Vir Biotechnology
VIR
$844M
$858K 0.85%
+150,312
CRBP icon
32
Corbus Pharmaceuticals
CRBP
$189M
$729K 0.72%
+57,644
NBP
33
NovaBridge Biosciences American Depositary Shares
NBP
$443M
$529K 0.52%
+139,886
BMEA icon
34
Biomea Fusion
BMEA
$71.4M
$505K 0.5%
250,000
IPSC icon
35
Century Therapeutics
IPSC
$47.3M
$231K 0.23%
462,963
CYTK icon
36
Cytokinetics
CYTK
$8.08B
– –
-61,103
IONS icon
37
Ionis Pharmaceuticals
IONS
$13.3B
– –
-98,267
LQDA icon
38
Liquidia Corp
LQDA
$2.79B
– –
-71,071
MLTX icon
39
MoonLake Immunotherapeutics
MLTX
$939M
– –
-17,623
NBIX icon
40
Neurocrine Biosciences
NBIX
$15B
– –
-40,608
OCUL icon
41
Ocular Therapeutix
OCUL
$2.49B
– –
-88,980
RARE icon
42
Ultragenyx Pharmaceutical
RARE
$3.22B
– –
-130,422
RCKT icon
43
Rocket Pharmaceuticals
RCKT
$342M
– –
-214,412
RNA icon
44
Avidity Biosciences
RNA
$10.8B
– –
-47,037
SLNO icon
45
Soleno Therapeutics
SLNO
$2.63B
– –
-33,691
SY
46
So-Young International
SY
$279M
– –
-72,936
UTHR icon
47
United Therapeutics
UTHR
$20.7B
– –
-4,874
VRNA
48
DELISTED
Verona Pharma
VRNA
– –
-68,982
WVE icon
49
Wave Life Sciences
WVE
$1.24B
– –
-70,242
KYTX icon
50
Kyverna Therapeutics
KYTX
$295M
– –
-142,542
1
2
3